@Article{Owczarczyk-Saczonek2015,
journal="Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii",
issn="1642-395X",
volume="32",
number="5",
year="2015",
title="The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years",
abstract=" Introduction : Cigarette smoking may exacerbate and cause psoriasis. Moreover, smokers are more likely to develop insulin resistance and metabolic syndrome (MS).    Aim:   To assess the prevalence of MS and its components in patients with psoriasis, who smoke, compared with the general Polish population of smokers.    Material and methods : We studied 29 patients with psoriasis (female = 9, male = 20), smokers, aged 30 to 49 years. Metabolic syndrome and its components were assessed using the IDF definition and compared to the results obtained in a representative sample of adult Poles in the NATPOL 2011 study in the same age group, including smokers.    Results:   The results have shown that patients with psoriasis are more likely to be smokers (p < 0.0034) and the frequency of smoking in men is approximately 25% higher than in males of the control group (p   0.05). Mean body mass index was 26.07 kg/m 2  in psoriasis patients and 25.59 kg/m 2  in the control group (p > 0.05), and abdominal obesity was 88.82 cm and 90.02 cm (p > 0.05), respectively. There were no differences in hypertension (34.48% vs. 31.6%, p   0.05). In lipid parameters, the differences were observed only in women with psoriasis – higher levels of HDL, triglycerides and ApoB/ApoA1 index compared with addicted women in the control group.   Conclusions : Men with psoriasis are more often addicted to smoking. Women with psoriasis who smoke have often disturbances of the lipid profile.",
author="Owczarczyk-Saczonek, Agnieszka B.
and Nowicki, Roman",
pages="331--336",
doi="10.5114/pdia.2015.54743",
url="http://dx.doi.org/10.5114/pdia.2015.54743"
}